(Allergan plc)

	AGN latest price $185.5527 (2.01%) ($182.5414 - $189.4616) on Fri. Dec. 9, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.19% (three month average)
RSI	51
Latest Price	$185.5527(2.01%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -0.3% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Value stock rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(44%)    SPY(43%)    ARKG(42%)
Factors Impacting AGN price	AGN will decline at least -1.095% in a week (0% probabilities).   VIXM(-29%)    TLT(-15%)    UUP(-14%)    SHY(-3%)    IPO(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.095% (StdDev 2.19%)
Hourly BBV	0 ()
Intraday Trend	1.6%

1 - 5 Day Possible Target	$181.91(-1.96%)
Resistance Level	$186.47
5 Day Moving Average	$183.88(0.91%)
10 Day Moving Average	$184.27(0.7%)
20 Day Moving Average	$186.47(-0.49%)
To recent high	-22%
To recent low	2%
Market Cap	$61.177b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed